日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Three-Year Long-Term Outcomes in Patients With Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab Treatment in Clinical Practice

临床实践中,采用阿特珠单抗联合贝伐珠单抗治疗不可切除肝细胞癌患者的三年长期疗效

Ohama, Hideko; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Tanaka, Hironori; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Kawata, Kazuhito; Naganuma, Atsushi; Kosaka, Hisashi; Matono, Tomomitsu; Kuroda, Hidekatsu; Yata, Yutaka; Nishikawa, Hiroki; Imai, Michitaka; Aoki, Tomoko; Ochi, Hironori; Tamai, Hideyuki; Komatsu, Shohei; Tada, Fujimasa; Nakamura, Shinichiro; Nakamura, Yoshiko; Miyake, Teruki; Yoshida, Osamu; Nouso, Kazuhiro; Morishita, Asahiro; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Tsutsui, Akemi; Nagano, Takuya; Tanaka, Kazunari; Matsuura, Takanori; Koshiyama, Yuichi; Kanayama, Yuki; Noritake, Hidenao; Enomoto, Hirayuki; Matsui, Kosuke; Kaibori, Masaki; Fukumoto, Takumi; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi

Sequential Fibrosis-4 Index and Mac-2 Binding Protein Glycosylation Isomer Combination Improve Detection of Advanced Fibrosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Multicenter Study

序贯纤维化-4指数和Mac-2结合蛋白糖基化异构体组合可提高代谢功能障碍相关脂肪肝疾病中晚期纤维化的检出率:一项多中心研究

Morishita, Asahiro; Kamada, Yoshihiro; Sumida, Yoshio; Arai, Taeang; Takahashi, Hirokazu; Seko, Yuya; Toyoda, Hidenori; Hayashi, Hideki; Yamaguchi, Kanji; Iwaki, Michihiro; Yoneda, Masato; Shima, Toshihide; Fujii, Hideki; Kawata, Kazuhito; Tomita, Kengo; Kawanaka, Miwa; Yoshida, Yuichi; Ikegami, Tadashi; Notsumata, Kazuo; Oeda, Satoshi; Atsukawa, Masanori; Fukushima, Hideaki; Kobara, Hideki; Miyoshi, Eiji; Aishima, Shinichi; Okanoue, Takeshi; Itoh, Yoshito; Nakajima, Atsushi

Alpha-Fetoprotein and Des-Gamma-Carboxy Prothrombin-Based Tumor Marker Score for First-Line Immunotherapy Selection in Hepatocellular Carcinoma

基于甲胎蛋白和去γ-羧基凝血酶原的肿瘤标志物评分在肝细胞癌一线免疫治疗选择中的应用

Tanaka, Kazunari; Tsuji, Kunihiko; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Toyoda, Hidenori; Koshiyama, Yuichi; Ogawa, Chikara; Nishikawa, Hiroki; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Noritake, Hidenao; Kawata, Kazuhito; Naganuma, Atsushi; Kosaka, Hisashi; Matsui, Kosuke; Matono, Tomomitsu; Kuroda, Hidekatsu; Yata, Yutaka; Tanaka, Hironori; Aoki, Tomoko; Tamai, Hideyuki; Tada, Fujimasa; Ohama, Hideko; Kanayama, Yuki; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Yoshida, Osamu; Imai, Michitaka; Nakamura, Shinichiro; Enomoto, Hirayuki; Kaibori, Masaki; Kudo, Masatoshi; Hiasa, Yoichi; Kumada, Takashi

Current management and future perspectives of covert hepatic encephalopathy in Japan: a nationwide survey

日本隐匿性肝性脑病的现状及未来展望:一项全国性调查

Miwa, Takao; Tsuruoka, Mio; Ueda, Hajime; Abe, Tamami; Inada, Hiroki; Yukawa-Muto, Yoshimi; Ohara, Masatsugu; Arai, Taeang; Tamai, Yasuyuki; Isoda, Hiroshi; Tadokoro, Tomoko; Hanai, Tatsunori; Ito, Takanori; Tamaki, Nobuharu; Sakamaki, Akira; Aoki, Yoshihiko; Tada, Fujimasa; Yoshio, Sachiyo; Takahashi, Hirokazu; Morishita, Asahiro; Ishikawa, Tsuyoshi; Inoue, Jun; Suda, Goki; Ogawa, Chikara; Atsukawa, Masanori; Hiraoka, Atsushi; Kuroda, Hidekatsu; Namisaki, Tadashi; Honda, Takashi; Kawaguchi, Takumi; Tanaka, Yasuhito; Terai, Shuji; Ikegami, Tadashi; Yoshiji, Hitoshi; Iwasa, Motoh; Shimizu, Masahito

Denosumab versus zoledronic acid for osteoporosis treatment in patients with primary biliary cholangitis (the DELTA Study): A multicenter, non-inferiority randomized trial

地诺单抗与唑来膦酸治疗原发性胆汁性胆管炎患者骨质疏松症的疗效比较(DELTA 研究):一项多中心、非劣效性随机试验

Arase, Yoshitaka; Okubo, Tomomi; Arai, Taeang; Abe, Masanori; Namisaki, Tadashi; Uojima, Haruki; Matsumoto, Kosuke; Kakisaka, Keisuke; Setsu, Toru; Mishima, Yusuke; Tsuruya, Kota; Hirose, Shunji; Deguchi, Ryuzo; Shiraishi, Koichi; Atsukawa, Masanori; Ikegami, Tadashi; Honda, Akira; Terai, Shuji; Yoshiji, Hitoshi; Komori, Atsumasa; Tanaka, Atsushi; Kagawa, Tatehiro

Accuracy of type IV collagen 7S versus Enhanced Liver Fibrosis score for diagnosing fibrosis in patients with metabolic dysfunction-associated steatotic liver disease

IV型胶原蛋白7S与增强型肝纤维化评分在诊断代谢功能障碍相关脂肪肝患者肝纤维化方面的准确性比较

Ishiba, Hiroshi; Fujii, Hideki; Kamada, Yoshihiro; Sumida, Yoshio; Takahashi, Hirokazu; Seko, Yuya; Toyoda, Hidenori; Hayashi, Hideki; Yamaguchi, Kanji; Iwaki, Michihiro; Yoneda, Masato; Arai, Taeang; Shima, Toshihide; Morishita, Asahiro; Kawata, Kazuhito; Tomita, Kengo; Kawanaka, Miwa; Yoshida, Yuichi; Ikegami, Tadashi; Notsumata, Kazuo; Oeda, Satoshi; Fukushima, Hideaki; Miyoshi, Eiji; Aishima, Shinichi; Itoh, Yoshito; Okanoue, Takeshi; Nakajima, Atsushi

Geriatric nutritional risk index and newly developed scoring system as prognosis prediction for unresectable hepatocellular carcinoma patients treated with lenvatinib

老年营养风险指数和新开发的评分系统可作为接受乐伐替尼治疗的不可切除肝细胞癌患者的预后预测指标

Ohama, Hideko; Hiraoka, Atsushi; Tada, Toshifumi; Hirooka, Masashi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Ochi, Hironori; Yasuda, Satoshi; Toyoda, Hidenori; Ogawa, Chikara; Nishimura, Takashi; Hatanaka, Takeshi; Kakizaki, Satoru; Shimada, Noritomo; Kawata, Kazuhito; Naganuma, Atsushi; Kosaka, Hisashi; Matono, Tomomitsu; Kuroda, Hidekatsu; Yata, Yutaka; Tanaka, Hironori; Nishikawa, Hiroki; Shibata, Hiroshi; Tada, Fujimasa; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Koizumi, Yohei; Nakamura, Shinichiro; Iijima, Hiroko; Kaibori, Masaki; Hiasa, Yoichi; Kumada, Takashi

Evaluation of Treatment Outcomes Using dNLR and GNRI in Combination Therapy With Atezolizumab and Bevacizumab for Hepatocellular Carcinoma

利用dNLR和GNRI评估阿特珠单抗联合贝伐珠单抗治疗肝细胞癌的疗效

Naganuma, Atsushi; Kakizaki, Satoru; Hiraoka, Atsushi; Tada, Toshifumi; Hatanaka, Takeshi; Kariyama, Kazuya; Tani, Joji; Atsukawa, Masanori; Takaguchi, Koichi; Itobayashi, Ei; Fukunishi, Shinya; Tsuji, Kunihiko; Ishikawa, Toru; Tajiri, Kazuto; Toyoda, Hidenori; Ogawa, Chikara; Nishikawa, Hiroki; Nishimura, Takashi; Kawata, Kazuhito; Kosaka, Hisashi; Hirooka, Masashi; Yata, Yutaka; Ohama, Hideko; Kuroda, Hidekatsu; Matono, Tomomitsu; Aoki, Tomoko; Kanayama, Yuki; Tanaka, Kazunari; Tada, Fujimasa; Nouso, Kazuhiro; Morishita, Asahiro; Tsutsui, Akemi; Nagano, Takuya; Itokawa, Norio; Okubo, Tomomi; Arai, Taeang; Imai, Michitaka; Nakamura, Shinichiro; Enomoto, Hirayuki; Kaibori, Masaki; Hiasa, Yoichi; Kudo, Masatoshi; Kumada, Takashi

Risk Stratification for Malignant Potential of Intraductal Papillary Mucinous Neoplasms Using the Apolipoprotein-A2 Isoforms Blood Test

利用载脂蛋白A2同工型血液检测对导管内乳头状黏液性肿瘤的恶性潜能进行风险分层

Hasegawa, Yuta; Itokawa, Norio; Kashiro, Ayumi; Kitamura, Michika; Nagashima, Kengo; Suzuki, Kenta; Higashi, Tetsuyuki; Shioda-Koyano, Kaori; Ono, Hiroki; Kawano, Tadamichi; Yoshida, Yuji; Okubo, Tomomi; Arai, Taeang; Hayama, Korenobu; Kaneko, Keiko; Atsukawa, Masanori; Takeuchi, Keiko; Futagami, Seiji; Iwakiri, Katsuhiko; Honda, Kazufumi

Association Between Laboratory Values and Covert Hepatic Encephalopathy in Patients with Liver Cirrhosis: A Multicenter, Retrospective Study

肝硬化患者实验室指标与隐匿性肝性脑病的相关性:一项多中心回顾性研究

Koyano, Kaori; Atsukawa, Masanori; Tsubota, Akihito; Kondo, Chisa; Miwa, Takao; Namisaki, Tadashi; Hiraoka, Atsushi; Toyoda, Hidenori; Tada, Toshifumi; Kobayashi, Yuji; Kawata, Kazuhito; Matsuura, Kentaro; Mikami, Shigeru; Kawabe, Naoto; Oikawa, Tsunekazu; Suzuki, Kenta; Kawano, Tadamichi; Okubo, Tomomi; Arai, Taeang; Tani, Joji; Morishita, Asahiro; Iwasa, Motoh; Ishikawa, Toru; Ikegami, Tadashi; Tanaka, Yasuhito; Shimizu, Masahito; Yoshiji, Hitoshi; Iwakiri, Katsuhiko